Glaxo, Merck to bring in cancer vaccines in India
GlaxoSmithKline and Merck will work with groups including the Bill and Melinda Gates Foundation to bring cervical cancer vaccines to the developing world over the next five years.
By Agencies |
LONDON: GlaxoSmithKline and Merck will work with groups including the Bill and Melinda Gates Foundation to bring cervical cancer vaccines to the developing world over the next five years.
PATH, a non-profit health organization, will research how to introduce the vaccines in India, Peru, Uganda and Vietnam with the help of a $27.8 million grant from the foundation, London-based Glaxo said.
Both Glaxo and Whitehouse Station, New Jersey-based Merck are expected to have approved vaccines available and will provide them to the project.
Glaxo, Europe's largest drug maker, has applied for European approval for its vaccine, Cervarix, and plans to seek US approval before the end of 2006.
PATH, a non-profit health organization, will research how to introduce the vaccines in India, Peru, Uganda and Vietnam with the help of a $27.8 million grant from the foundation, London-based Glaxo said.
Both Glaxo and Whitehouse Station, New Jersey-based Merck are expected to have approved vaccines available and will provide them to the project.
Glaxo, Europe's largest drug maker, has applied for European approval for its vaccine, Cervarix, and plans to seek US approval before the end of 2006.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
